Optimal surgery for gastric cancer: Is more always better?

Recent Results in Cancer Research

Volumn 196, Issue , 2012, Pages 215-227

  Allum, William H ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER CONTROL; CANCER INFILTRATION; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CARDIOPULMONARY EXERCISE TEST; CHEMORADIOTHERAPY; COMORBIDITY; ENDOSCOPIC MUCOSAL RESECTION; ENDOSCOPIC SURGERY; GASTRECTOMY; HEALTH CARE QUALITY; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; JAPANESE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MORBIDITY; MORTALITY; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; PANCREAS RESECTION; PATIENT SELECTION; PERIOPERATIVE PERIOD; PHASE 2 CLINICAL TRIAL (TOPIC); POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK BENEFIT ANALYSIS; SPLENECTOMY; STOMACH CANCER; STOMACH CARCINOMA; SURGICAL ANATOMY; SURGICAL APPROACH; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

EID: 84870002418     PISSN: 00800015     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-31629-6_15     Document Type: Article

References (39)

1. Bonenkamp JJ, Hermans J, Sasako M et al (1999) Extended lymph-node dissection for gastric cancer. N Engl J Med 340: 908-914
2. Cunningham D, Allum WH, Stenning SP et al (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355: 11-20
3. Cuschieri A, Weeden S, Fielding J et al (1999) Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical co-operative group. Br J Cancer 79: 1522-1530
4. De Manzoni G, Di Leo A, Roviello F et al (2011) Tumour site and perigastric nodal status are the most important predictors of para-aortic nodal involvement in advanced gastric cancer. Ann Surg Oncol 18: 2273-2280
5. Degiuli M, Sasako M, Ponti A, Calvo F (2004) Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer. Br J Cancer 90: 1727-1732
6. Degiuli M, Sasako M, Ponti A (2010) Morbidity and mortality in the Italian gastric cancer study group randomized clinical trial of D1 versus D2 resection for gastric cancer. Br J Surg 97: 643-649
7. Fukase K, Matsuda T, Suzuki M et al (1994) Evaluation of the efficacy of endoscopic treatment of gastric cancer considered in terms of long term prognosis. A comparison with surgical treatment. Dig Endosc 6: 241-247
8. Giovannini M, Berrardini D, Moutardier V et al (1999) Endoscopic mucosal resection (EMR): results and prognostic factors in 21 patients. Endoscopy 31: 698-701
9. Gotoda T, Yanagisawa A, Sasako M et al (2000) Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at 2 centres. Gastric Cancer 3: 219-225
10. Gunderson L, Sosin H (1982) Adenocarcinoma of the stomach: areas of failure in a reoperation series (second or symptomatic look) clinicopathological correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 8: 1-11
11. Hartgrink HH, Putter H, Klein Kranenbarg E (2002) Value of palliative resection in gastric cancer. Br J Surg 89: 1438-1443
12. Hermanek P (1995) pTNM and residual classifications: problems of assessment and prognostic significance. World J Surg 19: 184-190
13. Ida K, Kakazawa S, Yoshino J et al (2004) Multicentre collaborative prospective study of endoscopic treatment of early gastric cancer. Dig Endosc 16: 295-302
14. Japanese Gastric Cancer Association (2011) Japanese classification of gastric carcinoma - 3rd English edition. Gastric Cancer 14: 101-112
15. Jeong O, Choi WY, Park YK (2009) Appropriate selection of patients for combined organ resection in cases of gastric carcinoma invading adjacent organs. J Surg Oncol 100: 115-120
16. Kerkar SO, Kemp CD, Avital I (2010) Liver resections in metastatic gastric cancer HPB 12: 589-596
17. Kim JH, Jang YJ, Park SS et al (2009) Surgical outcomes and prognostic factors for T4 gastric cancers. Asian J Surg 32: 198-204
18. Kojima T, Parra-Blanco A, Takahashi H, Fujita R (1998) Outcome of endoscopic resection for early gastric cancer: review of the Japanese literature. Gastrointestinal Endosc 48: 550-555
19. Macdonald JS, Smalley SR, Benedetti J et al (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345: 725-730
20. McNeer G, Vandenberg H, Donn FY, Bowden LA (1951) A critical evaluation of subtotal gastrectomy for the cure of cancer of the stomach. Ann Surg 134: 2-7
21. Morita S, Katai H, Saka M et al (2008) Outcome of pylorus-preserving gastrectomy for early gastric cancer. Br J Surg 95: 1131-1135
22. National Oesophago-Gastric Cancer Audit (2009) Second annual report. The NHS Information Centre, U.K.
23. Nozaki I, Kubo Y, Kurita A et al (2008) Long term outcome after laparoscopic wedge resection for early gastric cancer. Surg Endosc 22: 2665-2669
24. Oda I, Gotada T, Hamanaka H et al (2005) Endoscopic mucosal dissection for early gastric cancer: technical feasibility, operation time and complications from a large consecutive series. Dig Endosc 17: 54-58
25. Oda I, Saito D, Tada M et al (2006) A multicentre retrospective study of endoscopic resection for early gastric cancer. Gastric Cancer 9: 262-270
26. Older P, Smith R, Hall A et al (2000) Preoperative cardiopulmonary risk assessment by cardiopulmonary exercise testing. Crit Care Resusc 2: 198-208
27. Roviello F, Pedrazzani C, Marrelli D et al (2010) Super-extended (D3) lymphadenectomy in advanced gastric cancer. Eur J Surg Oncol 36: 439-446
28. Sano T (2007) Tailoring treatments for curable gastric cancer. Br J Surg 94: 263-264
29. Sano T, Sasako M, Shibata S et al (2010) Randomized controlled trial to evaluate splenectomy in total gastrectomy for proximal gastric carcinoma (JCOG 0110): analyzes of operative morbidity, operation time, and blood loss. J Clin Oncol 28:15s. Abstract 4020
30. Sasako M, Sano T, Yamamoto S et al (2006) Left thoraco-abdominal approach versus abdominal transhiatal approach for gastric cancer of the cardia or subcardia: a randomised trial. Lancet Oncol 7: 644-651
31. Sasako M, Sano T, Yamamoto S (2008) D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med 359: 453-462
32. Siewert JR, Bottcher K, Roder JD et al (1993) Prognostic relevance of systematic lymph node dissection in gastric carcinoma. German gastric carcinoma study group. Br J Surg 80: 1015-1018
33. Sobin LH, Gospodarowicz MK, Wittekind C (2009) TNM Classification of malignant tumours, 7th edn. Wiley-Blackwell, John Wiley & Sons, Chichester
34. Songun I, Putter H, Kranenbarg EM et al (2010) Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 11: 439-449
35. Sue-Ling HM, Johnston D, Martin IG et al (1993) Gastric cancer: a curable disease. Br Med J 307: 591-596
36. Tada M, Tanaka Y, Matsuo N et al (2000) Mucosectomy for gastric cancer. Current status in Japan. J Gastroenterol Hepatol 15:D98-D102
37. Ueda K, Iwahashi M, Nakamori M et al (2009) Analysis of the prognostic factors and evaluation of surgical treatment for synchronous liver metastases from gastric cancer. Langenbecks Arch Surg 394: 647-653
38. Wu CW, Hsiung CA, Lo SS et al (2006) Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol 7: 309-315
39. Yokoyama H, Ikehara T, Kodera Y et al (2006) Biological significance of isolated tumour cells and micrometastasis in lymph nodes evaluated using a green fluorescent protein-tagged human gastric cancer cell line. Clin Cancer Res 15: 361-368